Literature DB >> 20023265

Comparison of two rapid assays for Clostridium difficile Common antigen and a C difficile toxin A/B assay with the cell culture neutralization assay.

Megan E Reller1, Romina C Alcabasa, Clara A Lema, Karen C Carroll.   

Abstract

We compared 3 rapid assays for Clostridium difficile with a cell culture cytotoxicity neutralization assay (CCNA). Of 600 stool samples, 46 were positive for toxigenic C difficile. Both rapid common antigen assays were highly sensitive (91.3%-100%) and, therefore, were appropriate screening tests. The rapid toxin assay had poor sensitivity (61%) but excellent specificity (99.3%). Testing stools for glutamate dehydrogenase (step 1) and those positive with a rapid toxin assay (step 2) would correctly classify 81% of submitted specimens within 2 hours, including during periods of limited staffing (evenings, nights, and weekends). CCNA could then be used as a third step to test rapid toxin-negative samples, thereby providing a final result for the remaining 19% of samples by 48 to 72 hours. The use of rapid assays as outlined could enhance timely diagnosis of C difficile.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023265     DOI: 10.1309/AJCPO3QWOU8CYGEU

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard.

Authors:  Torbjörn Norén; Ingegärd Alriksson; Josefin Andersson; Thomas Akerlund; Magnus Unemo
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

2.  Combination of culture, antigen and toxin detection, and cytotoxin neutralization assay for optimal Clostridium difficile diagnostic testing.

Authors:  Michelle J Alfa; Shadi Sepehri
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

Review 3.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

4.  Comparison of five assays for detection of Clostridium difficile toxin.

Authors:  Kimberle C Chapin; Roberta A Dickenson; Fongman Wu; Sarah B Andrea
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

5.  Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of clostridium difficile disease.

Authors:  Susan E Sharp; Lila O Ruden; Julie C Pohl; Patricia A Hatcher; Linda M Jayne; W Michael Ivie
Journal:  J Clin Microbiol       Date:  2010-04-07       Impact factor: 5.948

Review 6.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  Cost and Impact on Patient Length of Stay of Rapid Molecular Testing for Clostridium difficile.

Authors:  Bernadette Sewell; Eugene Rees; Ian Thomas; Chin Lye Ch'ng; Mike Isaac; Nidhika Berry
Journal:  Infect Dis Ther       Date:  2014-09-03

8.  The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.

Authors:  Xiao-qiang Yang; Ya-gang Zhao; Xue-qing Chen; Bo Jiang; Da-yong Sun
Journal:  BMC Gastroenterol       Date:  2013-07-17       Impact factor: 3.067

9.  SiMa Cells for a Serotype Specific and Sensitive Cell-Based Neutralization Test for Botulinum Toxin A and E.

Authors:  Nicola Bak; Shalini Rajagopal; Paul Stickings; Dorothea Sesardic
Journal:  Toxins (Basel)       Date:  2017-07-20       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.